iBio (IBIO) Research & Development (2016 - 2025)
Historic Research & Development for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $4.3 million.
- iBio's Research & Development rose 12802.34% to $4.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.0 million, marking a year-over-year increase of 14799.08%. This contributed to the annual value of $8.3 million for FY2025, which is 6030.86% up from last year.
- iBio's Research & Development amounted to $4.3 million in Q4 2025, which was up 12802.34% from $3.6 million recorded in Q3 2025.
- iBio's 5-year Research & Development high stood at $4.3 million for Q4 2025, and its period low was $904000.0 during Q1 2024.
- In the last 5 years, iBio's Research & Development had a median value of $2.3 million in 2021 and averaged $2.3 million.
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 43121.78% in 2021, then tumbled by 6580.94% in 2024.
- Quarter analysis of 5 years shows iBio's Research & Development stood at $1.9 million in 2021, then skyrocketed by 49.49% to $2.8 million in 2022, then tumbled by 44.76% to $1.5 million in 2023, then rose by 22.28% to $1.9 million in 2024, then surged by 128.02% to $4.3 million in 2025.
- Its Research & Development stands at $4.3 million for Q4 2025, versus $3.6 million for Q3 2025 and $3.2 million for Q2 2025.